NCT Number: NCT05336786
Phase: Phase 3
Trial Summary: This phase III trial investigates if perflutren lipid microspheres with ultrasound can be used to diagnose prostate cancer non-invasively. Definity (perflutren lipid microspheres) – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Thomas Jefferson University
Acronym:
An Imaging Agent (Perflutren Lipid Microspheres) With Ultrasound for Imaging of Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives